Treatment of Fungal Sinus Infections
For invasive fungal sinusitis, initiate voriconazole immediately combined with aggressive surgical debridement; if the organism is unknown or mucormycosis is suspected, start amphotericin B instead, as voriconazole lacks activity against mucormycosis. 1, 2
Classification-Based Treatment Approach
Treatment depends critically on distinguishing between invasive and non-invasive forms, as management differs dramatically 1, 2:
Invasive Fungal Sinusitis
Acute Invasive (Fulminant):
- Immediate combined medical-surgical intervention is essential 2, 3
- Start systemic antifungal therapy urgently before organism identification 1
- If organism unknown: Initiate amphotericin B formulation (liposomal amphotericin B 3-5 mg/kg/day IV) to cover potential mucormycosis 1, 3
- If Aspergillus confirmed: Switch to voriconazole (loading dose 6 mg/kg IV q12h for 1 day, then 4 mg/kg IV q12h maintenance) 1, 4, 5
- Critical warning: Voriconazole and itraconazole have NO activity against mucormycosis—using these agents empirically when mucormycosis is possible can be fatal 1, 3
- Aggressive surgical debridement of necrotic tissue via endoscopic approach 1, 2, 3
- Reduce immunosuppression when feasible 3
- Continue antifungal therapy for minimum 6 weeks after surgical intervention 2
Chronic Invasive (Indolent):
- Conservative endoscopic debridement combined with long-term oral antifungal therapy 6
- Voriconazole is effective as primary agent (can transition to oral after initial IV therapy: 200 mg PO twice daily) 5, 6
- Treatment duration extends for months; one series showed effective control with 1-27 months of therapy 6
- Associated strongly with diabetes mellitus—optimize glycemic control 3, 6
Non-Invasive Fungal Sinusitis
Fungal Ball (Mycetoma):
- Surgery alone is curative—antifungal medications are NOT required 2, 7, 8, 9
- Simple antrostomy or endoscopic removal is the primary treatment 2, 9
- Recurrence rate is only 3-4% with adequate surgical removal 2
- All cases in one series were cured by endoscopic sinus surgery without antifungal therapy 7, 9
Allergic Fungal Sinusitis:
- Meticulous exenterative endoscopic surgery to remove allergic mucin 10
- Systemic and topical corticosteroids (NOT antifungal agents) 8, 10
- Immunotherapy with relevant fungal and non-fungal antigens 10
- Regular nasal irrigation and self-cleansing 10
- Close endoscopic follow-up with debridement as needed 10
- Avoid systemic antifungals in invasive disease due to immunosuppressive effects 3
Organism-Specific Antifungal Selection
For Aspergillus species:
- Voriconazole is first-line (A-I level evidence) 1, 4, 5
- Alternative: Liposomal amphotericin B 3-5 mg/kg/day IV 4, 11
- Salvage options: Posaconazole, itraconazole, caspofungin, or micafungin 4
For Mucormycosis:
- Liposomal amphotericin B is mandatory first-line 3
- Triazoles (voriconazole, itraconazole, posaconazole) are completely ineffective 1, 3
For other organisms (Fusarium, Scedosporium):
- Voriconazole is indicated 5
Surgical Considerations
- Surgical debridement is an independent positive prognostic factor for survival (64% survival with endoscopic sinus surgery vs. lower without) 3
- Extent of surgery must be balanced against morbidity, especially in neutropenic patients 1
- Modern endoscopic approaches avoid disfiguring open procedures for maxillary and ethmoidal disease 1
- For CNS extension, surgical resection combined with voriconazole improves outcomes (35% favorable response, 31% long-term survival) 1
Monitoring and Duration
- Continue treatment throughout immunosuppression period and until radiographic lesion resolution 4
- Minimum treatment duration: 6-12 weeks for invasive disease 2, 4
- Serial CT imaging at regular intervals 4
- Regular endoscopic examination to detect early recurrence 2
Critical Pitfalls to Avoid
- Never use voriconazole or itraconazole empirically when organism is unknown—you may miss mucormycosis, which requires amphotericin B 1, 3
- Do not use antifungal medications for fungal balls or allergic fungal sinusitis—surgery alone (or surgery plus steroids for allergic) is appropriate 2, 8, 10, 9
- Avoid oral corticosteroids in invasive fungal disease due to additive immunosuppression 3
- Do not delay surgical intervention in acute invasive disease—mortality remains high (50-80%) despite treatment 3